Stockreport

New Kit Predicts Retroviral Particle Clearance in Biopharmaceutical Manufacturing

Maravai LifeSciences Holdings, Inc. - Class A common stock  (MRVI) 
PDF SOUTHPORT, N.C., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Cygnus Technologies, part of Maravai LifeSciences (Maravai) (NASDAQ: MRVI), the leading assay and services provider [Read more]